blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3178848

EP3178848 - TYPE II ANTI-CD20 ANTIBODY FOR REDUCING FORMATION OF ANTI-DRUG ANTIBODIES [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  04.07.2017
Database last updated on 20.09.2024
FormerThe application has been published
Status updated on  12.05.2017
Most recent event   Tooltip20.10.2017Refusal of applicationpublished on 22.11.2017  [2017/47]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
[2017/24]
Representative(s)Cueni, Leah Noëmi, et al
F. Hoffmann-La Roche AG
Patent Department
Grenzacherstrasse 124
4070 Basel / CH
[2017/24]
Application number, filing date15198715.309.12.2015
[2017/24]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3178848
Date:14.06.2017
Language:EN
[2017/24]
Search report(s)(Supplementary) European search report - dispatched on:EP03.05.2016
ClassificationIPC:C07K16/28, A61K39/395, C07K16/30
[2017/24]
CPC:
C07K16/2887 (EP); A61K38/2013 (EP); A61K39/3955 (EP);
A61K39/39558 (EP); A61K45/06 (EP); C07K16/2809 (EP);
C07K16/3007 (EP); A61K2039/505 (EP); A61K2039/507 (EP);
A61K2039/54 (EP); A61K2039/545 (EP); C07K2317/24 (EP);
C07K2317/31 (EP); C07K2319/00 (EP); C07K2319/75 (EP) (-)
C-Set:
A61K38/2013, A61K2300/00 (EP);
A61K39/39558, A61K2300/00 (EP);
A61K39/3955, A61K2300/00 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/24]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:TYPE II ANTI-CD20 ANTIKÖRPER ZUR VERRINGERUNG DER BILDUNG VON ANTIKÖRPERN GEGEN MEDIKAMENTE[2017/24]
English:TYPE II ANTI-CD20 ANTIBODY FOR REDUCING FORMATION OF ANTI-DRUG ANTIBODIES[2017/24]
French:ANTICORPS DE TYPE II CONTRE CD20 POUR LA REDUCTION DE LA FORMATION DES ANTICORPS CONTRE DES MÉDICAMENTS[2017/24]
Examination procedure03.07.2017Despatch of communication that the application is refused, reason: Examination on filing A.90(5) [2017/47]
13.07.2017Application refused, date of legal effect [2017/47]
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]WO2009134738  (GENENTECH INC [US], et al);
 [YD]WO2012107417  (ROCHE GLYCART AG [CH], et al);
 [Y]WO2012117002  (ROCHE GLYCART AG [CH], et al);
 [XY]WO2015095410  (GENENTECH INC [US], et al);
by applicantUS4518584
 US4676980
 US4816567
 EP0404097
 US5116943
 WO9301161
 US5206344
 US5208020
 WO9308829
 US5229109
 WO9316185
 WO9411026
 US5416064
 US5500362
 WO9627011
 EP0425235
 US5571894
 US5587458
 US5635483
 US5712374
 US5714586
 US5731168
 US5739116
 US5750373
 US5767285
 US5770429
 US5770701
 US5770710
 US5773001
 US5780588
 US5821337
 WO9850431
 US5869046
 US5877296
 US6075181
 US6150584
 US6248516
 EP1176195
 US2003115614
 US2003124678
 WO03056914
 US2003157108
 US6630579
 WO03084570
 WO03085119
 WO2004024927
 WO2004035607
 US2004093621
 US6737056
 US2004110282
 US2004110704
 WO2004056312
 US2004132140
 WO2004057002
 WO2004063351
 WO2004099249
 WO2004106381
 US2005079574
 WO2005044859
 US2005119455
 WO2005061547
 US6946292
 WO2005100402
 WO2005103081
 US2005266000
 US6982321
 US2006025576
 WO2006029879
 US7041870
 US7087409
 EP1691833
 WO2006121168
 WO2007005874
 US2007036752
 US7189826
 US2007061900
 WO2007031875
 WO2007042261
 US2007117126
 US2007160598
 WO2007110205
 US2007237764
 US2007292936
 EP1870459
 WO2007147901
 US7332581
 US2008069820
 WO2008034473
 WO2008119567
 US2009002360
 US7498298
 US7527791
 WO2009061853
 WO2009080251
 WO2009080252
 WO2009080253
 WO2009080254
 WO2009089004
 WO2009101611
 WO2009114335
 WO2010027827
 US7695936
 WO2010077634
 WO2010129304
 WO2011066342
 WO2011066389
 WO2011090754
 WO2011090762
 WO2011143545
 WO2012058768
 WO2012107417
 WO2012130831
 WO2012146628
 US2013034559
 WO2013026833
 WO2013096291
 WO2013157954
 WO2013157953
 WO2014131712
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.